NKTR
Nektar Therapeutics · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website nektar.com
- Employees(FY) 216
- ISIN US6402681083
Performance
+9.69%
1W
+17.79%
1M
+146.52%
3M
+247.73%
6M
+210.62%
YTD
+150.71%
1Y
Profile
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. The company is developing rezpegaldesleukin, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; and NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer squamous cell carcinoma and colorectal cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.
Technical Analysis of NKTR 2024-05-10
Overview:
In analyzing the technical indicators for NKTR over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the c...
Recent News & Updates
- 2024-05-10 04:41
- 2024-05-10 03:14
- 2024-05-09 23:33
- 2024-05-09 22:35
Q1 2024 Nektar Therapeutics Earnings Call(Yahoo Finance)
- 2024-05-09 05:39
Nektar: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-09 04:15
- 2024-05-02 06:00
- 2024-04-02 23:30
- 2024-03-24 22:00
- 2024-03-22 02:00
- 2024-03-05 23:33
- 2024-03-04 21:07
- 2024-03-04 20:13
- 2024-03-04 20:00
- 2024-03-04 18:19
Q4 2023 Nektar Therapeutics Earnings Call(Yahoo Finance)
- 2024-03-04 04:30
- 2024-03-04 03:51
- 2024-03-04 03:42
Nektar: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-03-04 03:15
- 2024-03-03 19:30
- 2024-02-27 05:00
- 2024-02-26 05:00
- 2024-02-19 21:00
- 2024-01-03 05:00
- 2023-12-11 05:00
- 2023-12-06 22:31
- 2023-11-08 19:39
- 2023-11-07 22:47
- 2023-11-07 04:28
Nektar: Q3 Earnings Snapshot(Yahoo Finance)
- 2023-11-07 03:15
Page 1 of 5
previousnext